The Sea of Uncertainty Surrounding Ductal Carcinoma In Situ--The Price of Screening Mammography
Authors:
Open Access
- 12 February 2008
- journal article
- research article
- Published by Oxford University Press (OUP) in JNCI: Journal of the National Cancer Institute
- Vol. 100 (4) , 228-229
Abstract
Wouldn’t it be easier if we lived in a binary world? Everything would be either black or white, yes or no, 1 or 0. And biopsy results would be either normal or cancer.Keywords
This publication has 18 references indexed in Scilit:
- Risk Perceptions and Psychosocial Outcomes of Women With Ductal Carcinoma In Situ: Longitudinal Results From a Cohort StudyJNCI: Journal of the National Cancer Institute, 2008
- Cancer Regression by SenescenceNew England Journal of Medicine, 2007
- Oncogene-Induced Cell Senescence — Halting on the Road to CancerNew England Journal of Medicine, 2006
- Increasing Incidence of Thyroid Cancer in the United States, 1973-2002JAMA, 2006
- Skin biopsy rates and incidence of melanoma: population based ecological studyBMJ, 2005
- Incidence of breast cancer in Norway and Sweden during introduction of nationwide screening: prospective cohort studyBMJ, 2004
- Cancer without diseaseNature, 2004
- Neuroblastoma Screening at One Year of AgeNew England Journal of Medicine, 2002
- Using Autopsy Series To Estimate the Disease “Reservoir” for Ductal Carcinoma in Situ of the Breast: How Much More Breast Cancer Can We Find?Annals of Internal Medicine, 1997
- Continued local recurrence of carcinoma 15–25 years after a diagnosis of low grade ductal carcinoma in situ of the breast treated only by biopsyCancer, 1995